Pharmacophore modeling and virtual screening are indispensable approaches in the process of identifying novel drug candidates. Pharmacophore modeling is a three-dimensional characterization of the molecular features required for the specific binding of a ligand to a target, while virtual screening is a computational technique used to screen potential drug candidates from large chemical libraries for compliance with pharmacophore models. At CD ComputaBio, we specialize in offering cutting-edge pharmacophore modeling and virtual screening services. Our expert team utilizes advanced computational methods and algorithms to perform detailed analyses of molecular structures.
At CD ComputaBio, we offer a range of services to accelerate the process of lead drug discovery and optimization using pharmacodynamic modeling and virtual screening. Our expertise in this area allows us to provide tailored solutions to meet the unique needs of each drug discovery project.
Our team specializes in creating high-quality pharmacophore models based on target structures and known ligands to efficiently identify compounds with desired biological activities.
Using powerful computational algorithms, we conduct virtual screening campaigns to prioritize compounds from large chemical libraries, saving time and resources in the early stages of drug discovery.
We use advanced tools to help with expansion and optimization, refining and expanding the chemical space, and improving the quality of lead compounds.
We conduct comprehensive validation studies to ensure the reliability and accuracy of the generated efficacy models and virtual screening results.
To initiate our pharmacophore modeling and virtual screening services, we require the following:
Sample Requirements | Descriptions |
Ligand Structures | Accurate 2D or 3D structures (in .mol or .sdf format) of the compounds to be analyzed. |
Target Proteins/Receptors | Detailed information on the target proteins, including their 3D structures (in .pdb or .fasta format) or available crystal structures. |
Upon completion of the potency modeling and virtual screening project, the client will receive a comprehensive report with the following deliverables:
Deliverables | >Descriptions |
Detailed Pharmacodynamic Model | Detailed description of the generated pharmacodynamic model, including key features and spatial arrangements required for ligand binding. |
Virtual Screening Results: | A list of compounds prioritized in the virtual screening campaign, along with associated molecular properties such as binding affinity predictions and structural details. |
Validation Reports | Extensive validation reports outlining the validation studies conducted to ensure the reliability and accuracy of the generated efficacy models and virtual screening results. |
CD ComputaBio offers state-of-the-art pharmacodynamic modeling and virtual screening services that provide researchers with predictive insights to accelerate the drug discovery and development process. By leveraging our expertise in algorithm development and computational analytics, we strive to deliver accurate, reliable and actionable results to our esteemed clients. Contact us today to learn more about our service information.